Cast or Functional Ankle Orthosis After Ankle Fracture Surgery

NCT ID: NCT06559111

Last Updated: 2025-04-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

134 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-12-01

Study Completion Date

2012-03-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this randomized clinical trial was to compare the effect of 6-week casting versus 2-week casting followed by 4-week ankle bracing in adult patients with surgically treated ankle fractures.

The primary outcome measures used were the functional results 3 months after surgery evaluated using two functional outcome measures (Olerud and Molander score and Kaikkonen score) and the patient return to work.

In the casting group, the traditional plaster was changed to a fiberglass one at 2 weeks and the cast treatment continued until 6 weeks. In the functional treatment group, the traditional plaster cast was changed to an reusable semi-rigid plastic orthosis (Aircast) at 2 weeks after surgery and its use was continued as an ankle support for up to 6 weeks. Follow-ups including subjective and objective evaluations were at 2, 6, 12 and 52 weeks and at 2 years postoperatively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ankle Fracture Postoperative Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bracing group

Participants in the bracing group had a cast for 2 weeks after the surgery followed by ankle brace for 4 weeks.

Group Type EXPERIMENTAL

2-week casting followed by 4-week bracing

Intervention Type DEVICE

Participants in the bracing group had a cast for 2 weeks after the surgery followed by ankle brace for 4 weeks.

Casting group

Participants in the casting group had a cast for 6 weeks after the surgery.

Group Type ACTIVE_COMPARATOR

6-week casting

Intervention Type DEVICE

Participants in the casting group had a cast for 6 weeks after the surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

2-week casting followed by 4-week bracing

Participants in the bracing group had a cast for 2 weeks after the surgery followed by ankle brace for 4 weeks.

Intervention Type DEVICE

6-week casting

Participants in the casting group had a cast for 6 weeks after the surgery.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Weber A or B type ankle fracture
* uni-, bi- or trimalleolar injury and/or fibular displacement of \>2 mm in any plane on the radiographs

Exclusion Criteria

* Weber C injury necessitating syndesmotic fixation
* Pilon injury
* Inadequate co-operation
* Other severe concomitant injuries
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tampere University Hospital

OTHER

Sponsor Role collaborator

Töölö Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lasse Rämö

Orthopaedic Surgeon

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Teppo Järvinen, Prof

Role: STUDY_CHAIR

Helsinki University Central Hospital

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

06121917

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.